Capricor Therapeutics Inc (LTS:0HTB)
€ 0.0 (0%) Market Cap: 5.45 Mil Enterprise Value: 5.45 Mil PE Ratio: 0 PB Ratio: 4.64 GF Score: 37/100

Capricor Therapeutics Inc Hope 3 Top Line Data Call Transcript

Dec 03, 2025 / 01:00PM GMT
Operator

Good morning ladies and gentlemen, and welcome to the Capricor Therapeutics HOPE-3 Phase 3 top-line data call. At this time, all lines are in a listen-only mode. Following the presentation, we will conduct a question-and-answer session.

(Operator Instructions) As a reminder, this conference call is being recorded. I would now like to turn the conference over to our host, Mr. AJ Bergmann, Capricor's Chief Financial Officer. Please go ahead.

Anthony Bergmann
Capricor Therapeutics Inc - Chief Financial Officer

Thank you and good morning, everyone. Before we start, I would like to state that we will be making certain forward-looking statements during today's presentation. Statements may include statements regarding, among other things, the efficacy, safety, and intended utilization of our product candidates, our future R&D plans, including their anticipated conduct and timing of pre-clinical and clinical studies, our enrollment in patients in our clinical studies, our plans to present or report additional data.

Our plans regarding regulatory

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot